[go: up one dir, main page]

WO2000009709A3 - Proteases et proteines associees - Google Patents

Proteases et proteines associees Download PDF

Info

Publication number
WO2000009709A3
WO2000009709A3 PCT/US1999/017818 US9917818W WO0009709A3 WO 2000009709 A3 WO2000009709 A3 WO 2000009709A3 US 9917818 W US9917818 W US 9917818W WO 0009709 A3 WO0009709 A3 WO 0009709A3
Authority
WO
WIPO (PCT)
Prior art keywords
pprg
associated proteins
proteases
provides
expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1999/017818
Other languages
English (en)
Other versions
WO2000009709A2 (fr
Inventor
Olga Bandman
Jennifer L Hillman
Mariah R Baughn
Yalda Azimzai
Karl J Guegler
Neil C Corley
Henry Yue
Y Tom Tang
Roopa Reddy
Chandra Patterson
Janice Au-Young
Leo L Shih
Dyung Aina M Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Priority to CA002338386A priority Critical patent/CA2338386A1/fr
Priority to JP2000565144A priority patent/JP2002522081A/ja
Priority to EP99939042A priority patent/EP1104473A2/fr
Priority to AU53403/99A priority patent/AU5340399A/en
Publication of WO2000009709A2 publication Critical patent/WO2000009709A2/fr
Publication of WO2000009709A3 publication Critical patent/WO2000009709A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

L'invention concerne des protéases et des protéines humaines associées (PRRG) ainsi que des polynucléotides identifiant et codant les PRRG. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne aussi des procédés pour diagnostiquer, traiter ou prévenir les maladies liées à l'expression des PRRG.
PCT/US1999/017818 1998-08-10 1999-08-06 Proteases et proteines associees Ceased WO2000009709A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002338386A CA2338386A1 (fr) 1998-08-10 1999-08-06 Proteases et proteines associees
JP2000565144A JP2002522081A (ja) 1998-08-10 1999-08-06 プロテアーゼ及び関連タンパク質
EP99939042A EP1104473A2 (fr) 1998-08-10 1999-08-06 Proteases et proteines associees
AU53403/99A AU5340399A (en) 1998-08-10 1999-08-06 Proteases and associated proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9611498P 1998-08-10 1998-08-10
US60/096,114 1998-08-10
US11976899P 1999-02-11 1999-02-11
US60/119,768 1999-02-11

Publications (2)

Publication Number Publication Date
WO2000009709A2 WO2000009709A2 (fr) 2000-02-24
WO2000009709A3 true WO2000009709A3 (fr) 2000-09-08

Family

ID=26791134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/017818 Ceased WO2000009709A2 (fr) 1998-08-10 1999-08-06 Proteases et proteines associees

Country Status (5)

Country Link
EP (1) EP1104473A2 (fr)
JP (1) JP2002522081A (fr)
AU (1) AU5340399A (fr)
CA (1) CA2338386A1 (fr)
WO (1) WO2000009709A2 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951924B2 (en) 1997-03-14 2005-10-04 Human Genome Sciences, Inc. Antibodies against secreted protein HTEBYII
WO1998040483A2 (fr) 1997-03-14 1998-09-17 Human Genome Sciences, Inc. 28 proteines secretees par l'homme
US6919433B2 (en) 1997-03-14 2005-07-19 Human Genome Sciences, Inc. Antibodies to protein HPMBQ91
CA2302387A1 (fr) 1997-08-29 1999-03-04 Human Genome Sciences, Inc. 29 proteines humaines secretees
EP1652924A3 (fr) * 1998-05-14 2006-09-13 Ono Pharmaceutical Co., Ltd. Polypeptide, l'ADNc qui la code et leur utilisation
WO2000023603A2 (fr) * 1998-10-21 2000-04-27 Arch Development Corporation Procede de traitement des diabetes de type 2
JP2003125777A (ja) * 1999-04-27 2003-05-07 Jenokkusu Soyaku Kenkyusho:Kk 花粉症関連遺伝子、５８１
US20020107381A1 (en) * 2000-09-29 2002-08-08 Friddle Carl Johan Novel human proteases and polynucleotides encoding the same
US20020151047A1 (en) * 2001-01-08 2002-10-17 Yi Hu Novel human protease and polynucleotides encoding the same
AU1939601A (en) * 1999-12-01 2001-06-12 Ludwig Institute For Cancer Research Cancer associated antigens and uses therefor
WO2001064919A2 (fr) * 2000-02-28 2001-09-07 Millennium Pharmaceuticals, Inc. 18036, une nouvelle protease semblable a la calpaïne, et utilisations de celle-la
WO2001088157A2 (fr) * 2000-05-16 2001-11-22 Millennium Pharmaceuticals, Inc. Methodes de traitement avec 17906 et utilisations de celles-ci
WO2002020736A2 (fr) * 2000-09-08 2002-03-14 Incyte Genomics Inc Proteases
ATE545651T1 (de) 2002-06-13 2012-03-15 Novartis Vaccines & Diagnostic Vektoren zur expression von hml-2-polypeptiden
WO2004104218A1 (fr) * 2003-05-23 2004-12-02 Bayer Healthcare Ag Agents diagnostiques et therapeutiques destines a des maladies associees a x-prolyl aminopeptidase 1 (xpnpep1)
FR2904223B1 (fr) * 2006-07-26 2013-01-11 Oreal Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique
WO2008012476A2 (fr) * 2006-07-26 2008-01-31 L'oreal Utilisation de carboxypeptidases dans le domaine cosmetique et therapeutique
DE102009010942A1 (de) * 2009-02-27 2010-09-02 Universitätsklinikum Schleswig-Holstein Serinprotease-Inhibitoren zur spezifischen Inhibition von Gewebs-Kallikreinen
ES2483724T3 (es) * 2009-03-30 2014-08-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarcadores, métodos y kits para el diagnóstico de artritis reumatoide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004387A1 (fr) * 1994-08-02 1996-02-15 Roussel Uclaf Sequences d'adn codant pour les proteines humaines tx et ty apparentees a l'enzyme de conversion de l'interleukine-1beta

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996004387A1 (fr) * 1994-08-02 1996-02-15 Roussel Uclaf Sequences d'adn codant pour les proteines humaines tx et ty apparentees a l'enzyme de conversion de l'interleukine-1beta

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BERNOT ET AL.: "A transcriptional map of the FMF region", GENOMICS, vol. 50, 1998, pages 147 - 160, XP002090815 *
BERNOT ET AL.: "Homo sapiens mRNA for metalloproteinase", EMBL SEQUENCE DATABASE, 21 January 1998 (1998-01-21), HEIDELBERG DE, XP002129491 *
BERNOT ET AL.: "Metalloproteinase", EMBL SEQUENCE DATABASE, 1 June 1998 (1998-06-01), HEIDELBERG DE, XP002129490 *

Also Published As

Publication number Publication date
AU5340399A (en) 2000-03-06
CA2338386A1 (fr) 2000-02-24
JP2002522081A (ja) 2002-07-23
WO2000009709A2 (fr) 2000-02-24
EP1104473A2 (fr) 2001-06-06

Similar Documents

Publication Publication Date Title
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2001012662A3 (fr) Proteines associees a la membrane
WO1999036550A3 (fr) Molecules de proteases humaines
WO2000015793A3 (fr) Proteines gpcr humaines
WO2000018922A3 (fr) Proteines humaines associees a des glucides
WO2000021988A3 (fr) Proteine humaine de la famille des ankyrines
WO2000034477A3 (fr) Proteines associees a des neurones
WO2000009709A3 (fr) Proteases et proteines associees
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000012711A8 (fr) Proteines membranaires de canal humaines
WO2000029583A3 (fr) Proteines de la superfamille des immunoglobulines
WO2000012703A3 (fr) Molecules associees au transport de proteines
WO2001020004A3 (fr) Proteines phosphatase et proteines kinase
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2000014251A3 (fr) Transferases humaines
WO1999049038A3 (fr) Proteines de fixation du calcium humaines
WO2000052151A3 (fr) Proteines de secretion humaines
WO1999058558A3 (fr) Proteines de signalisation cellulaire
WO1999061614A3 (fr) Proteines socs humaines
WO2000031263A3 (fr) Proteines associees a la gtpase
WO2000028045A3 (fr) Hydrolases humaines
WO2000042201A3 (fr) Peptidases humaines
WO2000023589A3 (fr) Proteines associees a la proliferation et a l'apoptose
WO2000001821A3 (fr) Proteines associees a la neurotransmission
WO2000008155A3 (fr) Proteines associees a un recepteur humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref document number: 2338386

Country of ref document: CA

Ref country code: CA

Ref document number: 2338386

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999939042

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999939042

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999939042

Country of ref document: EP